PFAS and Kidney Cancer

By David Meldofsky, California-licensed attorney · Founder, Lawsuit Informer

Last updated: June 1, 2026

Research has linked PFAS exposure, particularly the compound PFOA, to an increased risk of kidney cancer, most often renal cell carcinoma. The connection was first established in large studies of communities exposed to PFOA through contaminated drinking water, and in 2023 the International Agency for Research on Cancer classified PFOA as carcinogenic to humans. An established link is not the same as proof that PFAS caused any one person's cancer, which is a separate, fact-specific question.

For broader context, you can also start with PFAS water contamination lawsuits, review the current PFAS lawsuit update, or explore kidney cancer lawsuits and chemical exposure and kidney cancer.

Is There a Link Between PFAS and Kidney Cancer?

Yes, scientific research has identified an association between exposure to certain PFAS, especially PFOA, and an increased risk of kidney cancer. The kidney has been one of the most consistently reported sites in studies of people exposed to PFOA, alongside the testicles. This is one reason kidney cancer is frequently discussed in PFAS contamination research and litigation.

It is important to understand what an association means. Epidemiological studies can show that a group with higher PFAS exposure developed kidney cancer at higher rates than a comparison group. That is different from proving, in any individual case, that PFAS was the cause of that person's cancer. Individual causation depends on exposure level, duration, timing, family history, and other risk factors.

What the Research Shows

Several major lines of research inform the current understanding of PFAS and kidney cancer:

• The C8 Science Panel. Following litigation over PFOA contamination from a chemical plant in the Mid-Ohio Valley, an independent science panel studied roughly 69,000 highly exposed residents. The panel concluded there was a "probable link" between PFOA exposure and kidney cancer, as well as testicular cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension, and high cholesterol.
• The PLCO nested study. A later study drawing on a large U.S. cancer screening trial found that higher pre-diagnostic blood levels of PFOA were associated with an increased risk of renal cell carcinoma, supporting the earlier community findings in a different population.
• The IARC classification. In 2023, the International Agency for Research on Cancer, part of the World Health Organization, classified PFOA as carcinogenic to humans (Group 1), citing positive associations with kidney and testicular cancer among other evidence. A related PFAS compound, PFOS, was classified as possibly carcinogenic to humans (Group 2B).

Federal health agencies, including the Agency for Toxic Substances and Disease Registry, also list kidney cancer among the health effects studied in relation to PFAS exposure.

Why the Kidney May Be Affected

The kidney is a biologically plausible target for PFAS-related harm because of how the body handles these chemicals. PFAS such as PFOA are filtered by the kidneys and then substantially reabsorbed rather than excreted, which is part of why they persist in the body for years. That process means kidney tissue can experience prolonged contact with these compounds.

Researchers have also examined how PFAS may affect cellular processes, oxidative stress, and hormone signaling in ways that could contribute to cancer development. The exact biological mechanisms are still being studied, but the combination of epidemiological associations and mechanistic plausibility is part of why regulatory and scientific bodies have treated the kidney findings seriously.

Which PFAS Are Involved

PFAS are a large class of thousands of chemicals, and they have not all been studied equally. The strongest evidence regarding kidney cancer involves PFOA, one of the most widely produced and best-studied PFAS. PFOS has been studied as well and is classified as possibly carcinogenic. For most other individual PFAS compounds, the available human data on kidney cancer specifically is more limited.

To learn more about the chemicals themselves and the broader category of claims, see PFAS water contamination lawsuits and PFAS consumer product lawsuits.

How People Are Exposed

Kidney cancer concerns in PFAS research are usually tied to long-term exposure rather than a single event. The most commonly discussed exposure routes include:

• Contaminated public drinking water or private wells
• Living near manufacturing facilities, military bases, airports, or fire training sites
• Occupational exposure, including firefighting and chemical manufacturing
• Aqueous film-forming foam, often discussed in AFFF firefighting foam lawsuits

Symptoms of Kidney Cancer

Kidney cancer often causes no symptoms in its early stages and is sometimes found incidentally during imaging done for another reason. When symptoms do appear, they may include:

• Blood in the urine
• Persistent pain in the side or lower back
• A lump or mass in the side or abdomen
• Unexplained weight loss, fatigue, or persistent low-grade fever

These symptoms can have many causes unrelated to cancer. Only a qualified physician can evaluate them and make a diagnosis. This page is not a substitute for medical care.

PFAS, Kidney Cancer, and Lawsuits

Kidney cancer is one of the injuries most frequently discussed in PFAS and AFFF firefighting foam litigation. Individual injury claims generally turn on the person's exposure source, the timing and nature of the diagnosis, supporting medical records, and the applicable filing deadline. These individual claims are separate from public water system settlements, which generally address testing and cleanup costs rather than personal injury.

For the legal side, see Kidney Cancer Lawsuits, Cancers Linked to Lawsuits, and the PFAS Lawsuit Statute of Limitations by State. For general next steps, review What Evidence Helps a Lawsuit?, What Happens After You Contact a Lawyer?, and How Lawsuits Work.

Common Questions About PFAS and Kidney Cancer

Does PFAS cause kidney cancer?

Research has linked PFAS exposure, particularly PFOA, to an increased risk of kidney cancer, and in 2023 the International Agency for Research on Cancer classified PFOA as carcinogenic to humans. An established association is not the same as proof that PFAS caused any individual person's cancer, which depends on that person's exposure history, diagnosis, and other risk factors.

Which type of kidney cancer is linked to PFAS?

The kidney cancer most often discussed in PFAS research is renal cell carcinoma, the most common form of kidney cancer in adults. Studies of PFOA-exposed populations have most frequently reported associations with renal cell carcinoma.

How much PFAS exposure is needed to raise kidney cancer risk?

There is no established safe or unsafe threshold for an individual. Studies suggest higher and longer PFOA exposure is associated with greater risk, but risk in any single person depends on exposure level, duration, timing, and individual factors, so no specific dose can be said to cause kidney cancer.

Can people with kidney cancer file a PFAS lawsuit?

Kidney cancer is one of the injuries discussed in PFAS and AFFF firefighting foam litigation. Whether a particular person has a claim depends on their exposure source, diagnosis, medical records, and their state's filing deadline, and should be reviewed with qualified counsel. Learn more →

Sources

• C8 Science Panel, Probable Link Evaluation reports, Mid-Ohio Valley PFOA studies.
• Shearer JJ, et al. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma. Journal of the National Cancer Institute.
• International Agency for Research on Cancer (IARC), Monographs evaluation of PFOA and PFOS, 2023.
• Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological Profile for Perfluoroalkyls.
• U.S. Environmental Protection Agency, PFAS health effects materials.

Related PFAS and Illness Guides

About the Author

David Meldofsky is a California-licensed attorney and the founder of Lawsuit Informer.

He writes about lawsuits, toxic exposures, consumer safety issues, and legal process topics for readers seeking clear, accessible educational information.

Learn more about our Editorial Policy or Contact us.

The information on this page is provided for educational purposes and does not constitute legal advice.